CDSCO UID IMP/IVD/2023/000302_58a9837aaca33228f6ab493593c71699_96da9b7dfe0644b7039af0fc4e6607ae

Blood Lipid Analysis Meter

QMS MEDICAL ALLIED SERVICES LTD.·Device Class Class B·India CDSCO·Brand: Lysun
Registration details
UID
IMP/IVD/2023/000302_58a9837aaca33228f6ab493593c71699_96da9b7dfe0644b7039af0fc4e6607ae
Device class
Class B
Brand name
Lysun
Approving authority
CDSCO
Product information
The Blood Lipid Analysis System is intended for the quantitative determination of Total Cholesterol (Lysun), High Density Lipoprotein Cholesterol (Lysun), Triglycerides (Lysun), and the calculated ratio of TC/HDL and Low Density Lipoprotein Cholesterol (Lysun) in capillary blood, venous whole blood, plasma and serum
Similar products (3)
Other products with the same name or brand
Blood Lipid Test Strip
Brand: Lysun
QMS MEDICAL ALLIED SERVICES LTD.
Class B
Blood Lipid Analysis Meter
TULIP DIAGNOSTICS PRIVATE LIMITED
Class A
Blood Lipid Analysis Meter
Brand: LYSUN
ACCUREX BIOMEDICALS PVT. LTD.
Class A
Other products from QMS MEDICAL ALLIED SERVICES LTD.
Products from the same license holder (3 products)
Blood Lipid Test Strip
Brand: Lysun
Class B
Glycohemoglobin Test Kit
Brand: Biohermes
Class B
GluCoA1c Glycohemoglobin Analyzer
Brand: Biohermes
Class B
About this record

Blood Lipid Analysis Meter is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000302_58a9837aaca33228f6ab493593c71699_96da9b7dfe0644b7039af0fc4e6607ae. This device is marketed under the brand name Lysun. The license holder is QMS MEDICAL ALLIED SERVICES LTD., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.